Literature DB >> 32049533

Direct Cytosolic Delivery of Proteins through Coengineering of Proteins and Polymeric Delivery Vehicles.

Yi-Wei Lee1, David C Luther1, Ritabrita Goswami1, Taewon Jeon1,2, Vincent Clark1, James Elia1, Sanjana Gopalakrishnan1, Vincent M Rotello1.   

Abstract

Nanocarrier-mediated protein delivery is a promising strategy for fundamental research and therapeutic applications. However, the efficacy of the current platforms for delivery into cells is limited by endosomal entrapment of delivered protein cargo with concomitantly inefficient access to the cytosol and other organelles, including the nucleus. We report here a robust, versatile polymeric-protein nanocomposite (PPNC) platform capable of efficient (≥90%) delivery of proteins to the cytosol. We synthesized a library of guanidinium-functionalized poly(oxanorborneneimide) (PONI) homopolymers with varying molecular weights to stabilize and deliver engineered proteins featuring terminal oligoglutamate "E-tags". The polymers were screened for cytosolic delivery efficiency using imaging flow cytometry with cytosolic delivery validated using confocal microscopy and activity of the delivered proteins demonstrated through functional assays. These studies indicate that the PPNC platform provides highly effective and tunable cytosolic delivery over a wide range of formulations, making them robust agents for therapeutic protein delivery.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32049533      PMCID: PMC7392052          DOI: 10.1021/jacs.9b12759

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  39 in total

1.  Protein transduction domain mimics: the role of aromatic functionality.

Authors:  Abhigyan Som; Anika Reuter; Gregory N Tew
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-13       Impact factor: 15.336

Review 2.  50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond.

Authors:  Eric Verdin; Melanie Ott
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-30       Impact factor: 94.444

Review 3.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.

Authors:  Daniel Bobo; Kye J Robinson; Jiaul Islam; Kristofer J Thurecht; Simon R Corrie
Journal:  Pharm Res       Date:  2016-06-14       Impact factor: 4.200

4.  Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia.

Authors:  Susanne Kohl; Ditta Zobor; Wei-Chieh Chiang; Nicole Weisschuh; Jennifer Staller; Irene Gonzalez Menendez; Stanley Chang; Susanne C Beck; Marina Garcia Garrido; Vithiyanjali Sothilingam; Mathias W Seeliger; Franco Stanzial; Francesco Benedicenti; Francesca Inzana; Elise Héon; Ajoy Vincent; Jill Beis; Tim M Strom; Günther Rudolph; Susanne Roosing; Anneke I den Hollander; Frans P M Cremers; Irma Lopez; Huanan Ren; Anthony T Moore; Andrew R Webster; Michel Michaelides; Robert K Koenekoop; Eberhart Zrenner; Randal J Kaufman; Stephen H Tsang; Bernd Wissinger; Jonathan H Lin
Journal:  Nat Genet       Date:  2015-06-01       Impact factor: 38.330

5.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

Review 6.  Protein aggregation diseases: pathogenicity and therapeutic perspectives.

Authors:  Adriano Aguzzi; Tracy O'Connor
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 7.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

Authors:  Thomas Gaj; Charles A Gersbach; Carlos F Barbas
Journal:  Trends Biotechnol       Date:  2013-05-09       Impact factor: 19.536

8.  Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets.

Authors:  Haibao Zhu; Linlin Zhang; Sheng Tong; Ciaran M Lee; Harshavardhan Deshmukh; Gang Bao
Journal:  Nat Biomed Eng       Date:  2018-11-12       Impact factor: 25.671

Review 9.  Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging.

Authors:  Karina Cuanalo-Contreras; Abhisek Mukherjee; Claudio Soto
Journal:  Int J Cell Biol       Date:  2013-11-17

10.  The fluorination effect of fluoroamphiphiles in cytosolic protein delivery.

Authors:  Zhenjing Zhang; Wanwan Shen; Jing Ling; Yang Yan; Jingjing Hu; Yiyun Cheng
Journal:  Nat Commun       Date:  2018-04-10       Impact factor: 14.919

View more
  9 in total

1.  Direct Cytosolic Delivery of Proteins Using Lyophilized and Reconstituted Polymer-Protein Assemblies.

Authors:  David C Luther; Harini Nagaraj; Ritabrita Goswami; Yağız Anıl Çiçek; Taewon Jeon; Sanjana Gopalakrishnan; Vincent M Rotello
Journal:  Pharm Res       Date:  2022-03-16       Impact factor: 4.200

Review 2.  Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins.

Authors:  Yu Tian; Matthew V Tirrell; James L LaBelle
Journal:  Adv Healthc Mater       Date:  2022-03-23       Impact factor: 11.092

Review 3.  Genetic and Covalent Protein Modification Strategies to Facilitate Intracellular Delivery.

Authors:  Justin M Horn; Allie C Obermeyer
Journal:  Biomacromolecules       Date:  2021-12-02       Impact factor: 6.978

Review 4.  Accessing Intracellular Targets through Nanocarrier-Mediated Cytosolic Protein Delivery.

Authors:  Ritabrita Goswami; Taewon Jeon; Harini Nagaraj; Shumei Zhai; Vincent M Rotello
Journal:  Trends Pharmacol Sci       Date:  2020-09-02       Impact factor: 14.819

Review 5.  Protein Delivery: If Your GFP (or Other Small Protein) Is in the Cytosol, It Will Also Be in the Nucleus.

Authors:  David C Luther; Taewon Jeon; Ritabrita Goswami; Harini Nagaraj; Dongkap Kim; Yi-Wei Lee; Vincent M Rotello
Journal:  Bioconjug Chem       Date:  2021-04-19       Impact factor: 4.774

6.  Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier.

Authors:  Anshul Dhankher; Wei Lv; William T Studstill; Julie A Champion
Journal:  J Control Release       Date:  2021-09-24       Impact factor: 9.776

Review 7.  Biomedical polymers: synthesis, properties, and applications.

Authors:  Wei-Hai Chen; Qi-Wen Chen; Qian Chen; Chunyan Cui; Shun Duan; Yongyuan Kang; Yang Liu; Yun Liu; Wali Muhammad; Shiqun Shao; Chengqiang Tang; Jinqiang Wang; Lei Wang; Meng-Hua Xiong; Lichen Yin; Kuo Zhang; Zhanzhan Zhang; Xu Zhen; Jun Feng; Changyou Gao; Zhen Gu; Chaoliang He; Jian Ji; Xiqun Jiang; Wenguang Liu; Zhuang Liu; Huisheng Peng; Youqing Shen; Linqi Shi; Xuemei Sun; Hao Wang; Jun Wang; Haihua Xiao; Fu-Jian Xu; Zhiyuan Zhong; Xian-Zheng Zhang; Xuesi Chen
Journal:  Sci China Chem       Date:  2022-04-24       Impact factor: 10.138

8.  Different Biological Activities of Histidine-Rich Peptides Are Favored by Variations in Their Design.

Authors:  Morane Lointier; Candice Dussouillez; Elise Glattard; Antoine Kichler; Burkhard Bechinger
Journal:  Toxins (Basel)       Date:  2021-05-20       Impact factor: 4.546

9.  Enhanced Live-Cell Delivery of Synthetic Proteins Assisted by Cell-Penetrating Peptides Fused to DABCYL.

Authors:  Shaswati Mandal; Guy Mann; Gandhesiri Satish; Ashraf Brik
Journal:  Angew Chem Int Ed Engl       Date:  2021-02-22       Impact factor: 15.336

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.